Anne-Sophie Carret Selected Research

Anne-Sophie Carret Research Topics

16	Neoplasms (Cancer) 01/2024 - 09/2010
3	Brain Neoplasms (Brain Tumor) 01/2016 - 02/2008
3	Medulloblastoma 09/2015 - 05/2005
3	Hearing Loss (Hearing Impairment) 12/2014 - 08/2010
3	Ototoxicity 11/2014 - 05/2005
2	Lymphoma (Lymphomas) 05/2015 - 01/2014
2	Ependymoma 05/2015 - 04/2014
2	Glioma (Gliomas) 02/2014 - 02/2008
1	Exanthema (Rash) 01/2023
1	Fatigue 01/2023
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2019
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 05/2016
1	Pain (Aches) 01/2016
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2016
1	Astrocytoma (Pilocytic Astrocytoma) 08/2015
1	Inflammation (Inflammations) 05/2015
1	Lewis Lung Carcinoma 01/2014
1	Hemorrhage 02/2011
1	Choroid Plexus Carcinoma 02/2011
1	Choroid Plexus Papilloma 02/2011
1	Choroid Plexus Neoplasms (Choroid Plexus Tumor) 02/2011
1	Brain Stem Neoplasms (Brain Stem Tumor) 09/2010
1	Disease Progression 09/2010
1	Hodgkin Disease (Hodgkin's Disease) 03/2010
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 02/2008
1	Hypersensitivity (Allergy) 02/2008
1	Respiratory Tract Infections (Respiratory Tract Infection) 03/2007
1	Infections 03/2007
1	Paramyxoviridae Infections (Parainfluenza) 03/2007
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 03/2007

6	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 11/2014
4	pembrolizumabIBA 01/2024 - 01/2023
4	enfortumab vedotinIBA 01/2024 - 01/2023
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2015
2	PlatinumIBA 11/2014 - 08/2010
2	Carboplatin (JM8)FDA LinkGeneric 11/2014 - 02/2008
1	Lipase (Acid Lipase)FDA Link 01/2023
1	pyrrolo(2,1-c)(1,4)benzodiazepineIBA 01/2019
1	Immunoconjugates (Immunoconjugate)IBA 01/2019
1	Topotecan (Hycamtin)FDA LinkGeneric 05/2016
1	Diphosphonates (Bisphosphonates)IBA 01/2016
1	Syk KinaseIBA 12/2015
1	Indicators and Reagents (Reagents)IBA 05/2015
1	Enhancer of Zeste Homolog 2 ProteinIBA 05/2015
1	Y-Box-Binding Protein 1IBA 05/2015
1	ErbB Receptors (EGF Receptor)IBA 05/2015
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 05/2015
1	Biomarkers (Surrogate Marker)IBA 05/2015
1	Antineoplastic Agents (Antineoplastics)IBA 11/2014
1	Histones (Histone)IBA 05/2014
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 05/2014
1	Dactinomycin (Actinomycin)FDA LinkGeneric 01/2014
1	N- (2- (4- (4- chlorophenyl)piperazin- 1- yl)ethyl)- 3- methoxybenzamide (PB 12)IBA 11/2013
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 02/2011
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 02/2011
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 02/2011
1	Ribavirin (Virazole)FDA LinkGeneric 03/2007

13	Therapeutics 01/2023 - 03/2007
7	Drug Therapy (Chemotherapy) 12/2014 - 05/2005
2	Radiotherapy 05/2015 - 01/2015
1	Combination Drug Therapy (Combination Chemotherapy) 01/2023
1	Activities of Daily Living (ADL) 01/2016
1	Aftercare (After-Treatment) 08/2010
1	Hearing Aids (Hearing Aid) 08/2010
1	Chemoradiotherapy 05/2005